Gillian Powter

1.3k total citations
7 papers, 129 citations indexed

About

Gillian Powter is a scholar working on Hematology, Biochemistry and Infectious Diseases. According to data from OpenAlex, Gillian Powter has authored 7 papers receiving a total of 129 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Hematology, 3 papers in Biochemistry and 2 papers in Infectious Diseases. Recurrent topics in Gillian Powter's work include Platelet Disorders and Treatments (4 papers), Blood transfusion and management (3 papers) and SARS-CoV-2 and COVID-19 Research (2 papers). Gillian Powter is often cited by papers focused on Platelet Disorders and Treatments (4 papers), Blood transfusion and management (3 papers) and SARS-CoV-2 and COVID-19 Research (2 papers). Gillian Powter collaborates with scholars based in United Kingdom and Australia. Gillian Powter's co-authors include Simon Stanworth, Michael Murphy, Lise J Estcourt, Erica M. Wood, Claire Dyer, Andrew Mumford, Paul Harrison, D. R. Norfolk, Louise Choo and Charlotte Llewelyn and has published in prestigious journals such as The Lancet, Blood and British Journal of Haematology.

In The Last Decade

Gillian Powter

7 papers receiving 127 citations

Peers

Gillian Powter

HEMAT

BIOCH

CCICM

PRM

IM

P. Harms Germany

Ryosuke Miyaji Japan

Marta‐Inés Castillejo United States

Henna Wong United Kingdom

Cinzia Hu Italy

Gabriela Perez United States

Ursula La Rocca Italy

Dianne Plews United Kingdom

Tushar Sehgal India

Marı́a L. Marty Spain

P. Harms Germany

Gillian Powter

165 ×2.2

HEMAT

123 ×2.2

BIOCH

29 ×1.2

CCICM

23 ×1.1

PRM

22 ×1.3

IM

Citations per year, relative to Gillian Powter Gillian Powter (= 1×) peers P. Harms

Countries citing papers authored by Gillian Powter

Since Specialization

Citations

This map shows the geographic impact of Gillian Powter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gillian Powter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gillian Powter more than expected).

Fields of papers citing papers by Gillian Powter

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gillian Powter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gillian Powter. The network helps show where Gillian Powter may publish in the future.

Co-authorship network of co-authors of Gillian Powter

This figure shows the co-authorship network connecting the top 25 collaborators of Gillian Powter. A scholar is included among the top collaborators of Gillian Powter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gillian Powter. Gillian Powter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Mumford, Lisa, Rachel Hogg, Peter Lanyon, et al.. (2025). Impact of SARS-CoV-2 spike antibody positivity on infection and hospitalisation rates in immunosuppressed populations during the omicron period: the MELODY study. The Lancet. 405(10475). 314–328. 1 indexed citations

2.

Pearce, Fiona, Sean H. Lim, Mary Bythell, et al.. (2023). Antibody prevalence after three or more COVID-19 vaccine doses in individuals who are immunosuppressed in the UK: a cross-sectional study from MELODY. The Lancet Rheumatology. 5(8). e461–e473. 11 indexed citations

3.

Estcourt, Lise J, Zoe McQuilten, Gillian Powter, et al.. (2019). The TREATT Trial (TRial to EvaluAte Tranexamic acid therapy in Thrombocytopenia): safety and efficacy of tranexamic acid in patients with haematological malignancies with severe thrombocytopenia: study protocol for a double-blind randomised controlled trial. Trials. 20(1). 592–592. 15 indexed citations

4.

Stanworth, Simon, Michael Desborough, Gillian Powter, et al.. (2018). Clinical bleeding and thrombin generation in admissions to critical care with prolonged prothrombin time: an exploratory study. Transfusion. 58(6). 1388–1398. 4 indexed citations

5.

Estcourt, Lise J, Simon Stanworth, Paul Harrison, et al.. (2014). Prospective observational cohort study of the association between thromboelastometry, coagulation and platelet parameters and bleeding in patients with haematological malignancies‐ The ATHENA study. British Journal of Haematology. 166(4). 581–591. 40 indexed citations

6.

Stanworth, Simon, Lise J Estcourt, Gillian Powter, et al.. (2012). The Effect of a No-Prophylactic Versus Prophylactic Platelet Transfusion Strategy On Bleeding in Patients with Hematological Malignancies and Severe Thrombocytopenia (TOPPS trial). A Randomized Controlled, Non-Inferiority Trial. Blood. 120(21). 1–1. 21 indexed citations

7.

Stanworth, Simon, Claire Dyer, Louise Choo, et al.. (2010). Do All Patients With Hematologic Malignancies and Severe Thrombocytopenia Need Prophylactic Platelet Transfusions?. Transfusion Medicine Reviews. 24(3). 163–171. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact